Haemophilia A & B Gene Panel in UAE | 4800 AED | DHA Approved Guidelines

Executive Summary & Core Metrics

✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.

✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).

✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance with result interpretation by specialist.

✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Haemophilia A & B Gene Panel is a comprehensive genetic test that utilizes Next-Generation Sequencing (NGS) to detect pathogenic variants in the F8 and F9 genes, providing definitive diagnosis and carrier status. It is designed for diagnostic confirmation, carrier screening, and prenatal planning, adhering to DHA approved guidelines with a 4–6 week turnaround time and 99.9% analytical sensitivity.

Feature	Our Test (NGS Panel)	Closest Alternative (Targeted Sanger)
Methodology	Next-Generation Sequencing (NGS) with full F8/F9 gene coverage, CNV analysis	Sanger sequencing of selected exons
Diagnostic Sensitivity	>99.9% for all variant types	~95% (only hotspot regions)
Turnaround Time	4 – 6 weeks	3 – 4 weeks
Price	4800 AED	Varies (often partial testing)
Regulatory Approval	DHA Approved, ISO 9001:2015	May lack full accreditation

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics, I emphasize that genetic testing must always be interpreted in the context of personal and family history, coagulation factor levels, and clinical symptoms to avoid false reassurance. While this test provides critical information, a negative result does not exclude haemophilia if other risk factors persist. Please ensure you discuss your results with a haematologist for a comprehensive care plan.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory: Medication Safety

Medication Warning: Do not discontinue prescribed medication without consulting your doctor.

Exclusion Criteria & Red Flags

Exclusion Criteria: Active bleeding episode requiring emergency care; recent transfusion (< 2 weeks); inability to provide peripheral blood sample.
ER Red Flags (Seek immediate medical attention): Sudden severe joint swelling or pain; severe headache with altered consciousness (possible intracranial bleeding); chest pain or difficulty breathing; large spontaneous hematomas.

If any of these occur, go to the nearest emergency department or call 998/999.

Patient FAQ & Clinical Guidance

1. What is the purpose of the Haemophilia A & B gene panel?

This genetic test identifies mutations in F8 and F9 genes to diagnose haemophilia A or B, determine carrier status, and guide family planning. It also helps classify the severity and enables prenatal diagnosis when indicated.

2. How is the sample collected and what preparation is needed?

A small peripheral blood sample is collected through our ISO-certified VIP home phlebotomy service with no fasting required. You must provide a valid doctor’s prescription (exceptions for surgery, pregnancy, or travel abroad) and avoid blood transfusions two weeks prior.

3. What do the results mean and how will I receive them?

Your secure PDF report will detail any detected pathogenic variants, clinical significance, and carrier risk with telephonic guidance. A negative result reduces haemophilia likelihood but does not completely exclude it; clinical correlation is essential.

UAE Regulatory & Data Privacy Adherence

100% Compliant with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) & Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – Quality Management for Diagnostic Services. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name	Haemophilia A & B Gene Panel
Price (AED)	4800 AED
Turnaround Time	4 – 6 weeks
Sample Type / Matrix	Peripheral whole blood
Methodology Used	Next-Generation Sequencing (NGS) with full F8/F9 gene coverage, CNV analysis
ICD-10-CM Code	D66, D67
LOINC Code	90604-7
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab Branding: DNA Labs UAE.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians